Product Information
EXENATIDE 10 MCG DOSE PEN INJ is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $300.1675 per ML under NDC 70121168601. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Nov 19, 2024.
Strength
250 ug/mL
Manufacturer
Amneal Pharmaceuticals LLCNDC
70121168601
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
7/22/2026
Active Ingredients
EXENATIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206697FDA Approved
11/19/2024
On Market Since
11/22/2024
Pharmacological Classes
Price Statistics
The NADAC for EXENATIDE 10 MCG DOSE PEN INJ has been published 50 times since Oct 22, 2025, and over the history we have for it it has risen 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $300.1675 per ML |
|---|---|
| All-time high | $300.1675 (Sep 30, 2026) |
| All-time low | $276.0163 (Jan 21, 2026) |
| 52-week high | $300.1675 |
| 52-week low | $276.0163 |
| Median price | $299.5033 |
| Average price | $291.0745 |
| Largest weekly change | +4.4% (Mar 18, 2026) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Exenatide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Exenatide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
GLP-1 Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EXENATIDE 10 MCG DOSE PEN INJ?
The current National Average Drug Acquisition Cost (NADAC) for EXENATIDE 10 MCG DOSE PEN INJ, manufactured by Amneal Pharmaceuticals LLC, is $300.1675 per ML (NDC 70121168601), effective Sep 30, 2026.
How has the price of EXENATIDE 10 MCG DOSE PEN INJ changed over time?
Over the history we have for it, the NADAC for EXENATIDE 10 MCG DOSE PEN INJ has risen 8.2%. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for EXENATIDE 10 MCG DOSE PEN INJ?
Since Oct 22, 2025, the NADAC for EXENATIDE 10 MCG DOSE PEN INJ has ranged from a low of $276.0163 (Jan 21, 2026) to a high of $300.1675 (Sep 30, 2026), with a median of $299.5033 per ML.
Are there cheaper alternatives to EXENATIDE 10 MCG DOSE PEN INJ?
No other NADAC-published product currently shares the active ingredient and strength of EXENATIDE 10 MCG DOSE PEN INJ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EXENATIDE 10 MCG DOSE PEN INJ?
EXENATIDE 10 MCG DOSE PEN INJ (NDC 70121168601) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.